Purchase Order 75N95023P00452
Award Date 7/19/23
Potential Completion Date 7/18/24
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $11,210.00 Firm Fixed Price Purchase Order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH, a foreign-owned for-profit limited liability company. The contract, which does not have a set-aside designation, is for the delivery of custom order quantities of the SDM-8 tin precursor compound in 200 mg, 10 mg, and 5 mg vials. The place of...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $12,087 purchase order to Med Associates, Inc., doing business as Med Associates, for unspecified services or products. The contract has a one-year period of performance beginning July 7, 2023 through July 6, 2024 and utilizes a firm fixed price contracting structure. Place of performance will be Med Associates' Baltimore, Maryland location. No additional details were...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $11,685 purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. The firm fixed price contract is to provide research and development systems in support of NIH/NIDA programs addressing substance abuse and addiction. Performance will take place in Minneapolis over a two week period concluding on August 1, 2023. No subcontractors or set aside designations were...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,825 purchase order to Sigma-Aldrich, Inc. for contract 1107546 under contract number 23-005532. Performance will take place in Baltimore, Maryland over the course of one year beginning in September 2023. The firm fixed price contract is for the procurement of products or services to support NIH/NIDA research efforts, though details of the work were not provided....
- The National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health, awarded a purchase order to Bio Image Systems, Inc. for a Cell Vivo Bioarray Matrix (BAM) instrument and associated disposables, a cell culture system valued at $93,000. The contract, which was awarded on September 10, 2020, with an ultimate completion date of October 31, 2020, carries firm fixed-price terms with no set-aside designation. Performance will take place in Jackson, Michigan. This...
- The National Institute on Drug Abuse issued a purchase order to Avista Pharma Solutions, Inc. (doing business as Cambrex) on December 31, 2020, valued at $2,086,294.30 for the acquisition of cGMP-grade GS-441524 drug substance to support COVID-19 treatment research. Place of performance is Durham, North Carolina. The order calls for manufacturing of cGMP-grade GS-441524 to support preclinical and Phase I clinical studies evaluating the drug's safety, tolerability, efficacy, pharmacokinetics, and...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $46,418 firm fixed price delivery order against the Scientific, Operations, and Administrative Resources to the National Institutes of Health indefinite-delivery/indefinite-quantity multiple award contract vehicle. Medical Science & Computing, LLC will serve as the prime contractor providing research support services to further the National Institute on Drug Abuse's mission...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,656.84 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation. The contract is to provide Lindsay Kryszak with a custom SimplePlex cartridge kit for 32 samples to support protein analysis. Performance will occur in Baltimore, Maryland over a one year period from December 2023 through December 2024. No subcontractors or set aside designations...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,978.26 firm fixed price purchase order to Neuronexus Technologies, Inc., doing business as Nuvectra, for data acquisition printed circuit boards to support scientific research. The contract has a period of performance of September 7, 2023 through September 6, 2024. Place of performance will be Nuvectra's facilities in Baltimore, Maryland. No set aside designation or...
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $105,000 firm fixed price purchase order to New York Stem Cell Foundation Inc. as the prime contractor. The contract is to support the agency's research efforts and will be performed in New York, New York over a one year period from September 2023 through September 2024. No major subcontractors or set aside designations were indicated. The National Institute on Drug Abuse...